Cardiovascular-Kidney-Metabolic Syndrome Toolkit
Screening, staging, and treatment resources for cardiovascular-kidney-metabolic syndrome
Cardiovascular-kidney-metabolic (CKM) syndrome is a distinct epidemiological and prognostic disease characterized by the co-occurrence of cardiovascular disease, chronic kidney disease, and type 2 diabetes. Approximately 90% of adults in the US are at risk for or have CKM syndrome. With new 2026 guidelines now available on the prevention, detection, and management of CKM, this toolkit is designed to help providers and patients recognize risk factors and understand prevention, screening, staging, and treatment to encourage longitudinal assessment and prevent irreversible disease progression.
Featured Resources for Providers
Resources for Providers
Resources for Patients
Videos
CKM Syndrome and the Importance of Early Detection and Intervention
In this four-part series, PA Viet Le breaks down the staging, screening, and treatment of Cardio-Kidney-Metabolic (CKM) syndrome through practical guidance and real-world patient cases.
A Practical Look at CKM Syndrome
This four-part video series by PA Viet Le offers a practical, clinically grounded look at Cardio-Kidney-Metabolic (CKM) syndrome, exploring its progression, screening guidelines, treatment options, and patient-centered care strategies.
Created with support from Bayer.
